| answer text |
<p>A total of £136,000 has been awarded to the University of St Andrews under the</p><p>provisions
of NHS Act 2006 Para 13 Schedule.</p><p>The terms of reference are as follows:</p><p>
</p><p>- The trials and assessment will be carried out by the University of St. Andrew;</p><p>-
The Funding Period started on 1 March 2021 and ends on 28 February 2022 unless terminated
earlier in accordance with this Grant Funding Agreement; and</p><p>- The Grant Recipient
shall provide the Authority with a quarterly report on the progress of the trials
on evaluating the efficacy of viricidal Far-UVC light technology and its ability to
inactivate virus in droplets, aerosols and on surfaces in simulated public locations.</p><p>
</p><p>Initial results are expected in Quarter 4 2021.</p>
|
 |
